Latest News

FDA Approves Inotuzumab for Pediatric Patients with ALL
FDA Approves Inotuzumab for Pediatric Patients with ALL

March 6th 2024

The FDA has approved inotuzumab for the treatment of pediatric patients 1 year or older with acute lymphoblastic leukemia.

Investigating Beyond the First-Generation BTK Inhibitors in CLL
Investigating Beyond the First-Generation BTK Inhibitors in CLL

March 5th 2024

Novel CAR T-Cell Therapy Extends PFS in CLL
Novel CAR T-Cell Therapy Extends PFS in CLL

February 17th 2024

Managing Cardiac Toxicities with Zanubrutinib in Relapsed CLL
Managing Cardiac Toxicities with Zanubrutinib in Relapsed CLL

February 14th 2024

FDA Lifts Clinical Hold on CAR T Study in AML
FDA Lifts Clinical Hold on CAR T Study in AML

February 12th 2024

Video Series
Video Interviews

More News